Back
Traws Pharma 10K Form
Buy
56
TRAW
Traws Pharma
Last Price:
$8.08
Seasonality Move:
4.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TRAW News And Ratings
See the #1 stock for the next 7 days that we like better than TRAW
TRAW Financial Statistics
Sales & Book Value
| Annual Sales: | $226K |
|---|---|
| Cash Flow: | $-11.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.67 |
| Price / Book: | 2.78 |
Profitability
| EPS (TTM): | -141.47000 |
|---|---|
| Net Income (TTM): | $-140.8M |
| Gross Margin: | -- |
| Return on Equity: | -124.39% |
| Return on Assets: | -736.98% |
Traws Pharma Earnings Forecast
Key Traws Pharma Financial Ratios
-
The Research & Development expenses have been 5,057.52% of Revenue.
-
The Net Earning history of TRAW is -8,384.07% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 10 years.
Traws Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TRAW |
| Website: | onconova.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.07 |
| Quick Ratio: | 0.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TRAW Technical Analysis vs Fundamental Analysis
Buy
56
Traws Pharma (TRAW)
is a Buy
Is Traws Pharma a Buy or a Sell?
-
Traws Pharma stock is rated a BuyThe current Traws Pharma [TRAW] share price is $8.06. The Score for TRAW is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.